InnerMedical Co., Ltd, a leading chronic disease diagnosis and treatment solutions provider based in Shenzhen, has reportedly raised close to RMB 300 million (USD 42.9 million) in a Series D financing round. The round was led by Green Pine Capital Partners and Simiao Capital, with participation from Cornerstone Investment, Chengshang Investment, Minsheng Securities, Huathaixin Medical Investment, Dice Venture Capital, Anxin Light Salt Medicine Health Industry Investment Fund, and Shenzhen Longgang Financial Investment Holding. The funds will be used to advance the company’s novel product pipeline, research and development, manufacturing capacity, market expansion, and team building.
Company Background and Achievements
Founded in 2015, InnerMedical has established itself as a pioneer in the field of chronic disease solutions. The company specializes in ultrasonic endoscopes, electronic endoscopes, vascular imaging system equipment, and consumables, focusing on gastrointestinal/respiratory tract tumors and cardiovascular diseases. In August 2021, InnerMedical launched the first ultrasonic diagnostic equipment for endoscopes in China, making it the third company in the world to master this advanced technology.-Fineline Info & Tech
